{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:02:12Z","timestamp":1793275332577,"version":"4.5.0"},"reference-count":140,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institute for Health and Care Research Biomedical Research Centre","id":[{"id":"https:\/\/ror.org\/0187kwz08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2024,5,3]]},"DOI":"10.1080\/13543784.2024.2348738","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:17:15Z","timestamp":1715987835000},"page":"451-467","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":32,"title":["Inflammation and Huntington\u2019s disease \u2013 a neglected therapeutic target?"],"prefix":"10.1080","volume":"33","author":[{"given":"Sophie E.","family":"Field","sequence":"first","affiliation":[{"name":"Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, and MRC-WT Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel J.","family":"Curle","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, and MRC-WT Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Barker","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, John van Geest Centre for Brain Repair, and MRC-WT Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0389-4"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00453"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00120-X"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-1-19"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30143-5"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.125"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2016.02.006"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052358"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2020.00198"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4338"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2022.10.020"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn.3668"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46852-z"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-00293-z"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20526"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp239"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2008.05823.x"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01782-9"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.09.003"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11441-0"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02963-y"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddz009"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-198511000-00003"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/60.2.161"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2014.06.004"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26753"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1999.7170"},{"key":"e_1_3_4_30_1","article-title":"Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington\u2019s disease","author":"Wilton DK","year":"2023","unstructured":"Wilton DK, Mastro K, Heller MD, et al. Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington\u2019s disease. Nat Med. 2023.","journal-title":"Nat Med"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25354"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1487-12.2012"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000222734.56412.17"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2006.10.029"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn244"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.21008"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.08.011"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00072"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad084"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000984"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy202"},{"issue":"22","key":"e_1_3_4_42_1","first-page":"4920","article-title":"A small molecule p75NTR ligand normalizes signalling and reduces Huntington\u2019s disease phenotypes in R6\/2 and BACHD mice","volume":"25","author":"Simmons DA","year":"2016","unstructured":"Simmons DA, Belichenko NP, Ford EC, et al. A small molecule p75NTR ligand normalizes signalling and reduces Huntington\u2019s disease phenotypes in R6\/2 and BACHD mice. Hum Mol Genet. 2016;25(22):4920. Available from: \/pmc\/articles\/PMC5418739\/","journal-title":"Hum Mol Genet"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01023-8"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30255-8"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30346-X"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12139"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/77528"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1832501100"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-022-01511-5"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2005.11.002"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10818"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-816X.2004.03372.x"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10614"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23236"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2018.05.007"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113216"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-150277"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1190928"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00390-x"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1094503"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq212"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109308"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt036"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911503106"},{"issue":"3","key":"e_1_3_4_65_1","first-page":"487","article-title":"Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington\u2019s disease mouse model","volume":"28","author":"Wood TE","year":"2019","unstructured":"Wood TE, Barry J, Yang Z, et al. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington\u2019s disease mouse model. Hum Mol Genet. 2019;28(3):487\u2013500. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30312396\/","journal-title":"Hum Mol Genet"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11758"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199111000-00005"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-0880-6"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw8546"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad275"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.10.008"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M705467200"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903302"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.01.002"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01919-8"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.04.021"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147813"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24406"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2014.10.012"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29792-x"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0431"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2020.06.008"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20080178"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt355"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64565"},{"key":"e_1_3_4_86_1","first-page":"10","article-title":"Mutant Huntingtin does not affect the intrinsic phenotype of human huntington\u2019s disease t lymphocytes","author":"Miller JRC","year":"2015","unstructured":"Miller JRC, Tr\u00e4ger U, Andre R, et al. Mutant Huntingtin does not affect the intrinsic phenotype of human huntington\u2019s disease t lymphocytes. PLoS One. 2015:10. Available from: \/pmc\/articles\/PMC4631523\/","journal-title":"PLoS One"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24408"},{"key":"e_1_3_4_88_1","first-page":"13","article-title":"Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington\u2019s disease","author":"Niemel\u00e4 V","year":"2018","unstructured":"Niemel\u00e4 V, Burman J, Blennow K, et al. Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington\u2019s disease. PLoS One. 2018:13. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29474427\/","journal-title":"PLoS One"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25647"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNR.0b013e32832e34ee"},{"key":"e_1_3_4_91_1","first-page":"113:E6145","article-title":"Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor","author":"Kaye J","year":"2016","unstructured":"Kaye J, Piryatinsky V, Birnberg T, et al. Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A. 2016:113:E6145\u2013E6152. Available from: https:\/\/www.pnas.org\/doi\/abs\/10.1073\/pnas.1607843113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep31652"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04990-1"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00454-4"},{"key":"e_1_3_4_95_1","first-page":"13","article-title":"Weight changes in Huntington\u2019s disease","author":"Robbins AO","year":"2006","unstructured":"Robbins AO, Ho AK, Barker RA Weight changes in Huntington\u2019s disease. Eur J Neurol. 2006:13. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16879284\/.","journal-title":"Eur J Neurol"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2011.05.006"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S384949"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2023.12.023"},{"key":"e_1_3_4_99_1","first-page":"10","article-title":"Alterations in the gut fungal community in a mouse model of Huntington\u2019s disease","author":"Kong G","year":"2022","unstructured":"Kong G, Cao K-A L, Hannan AJ Alterations in the gut fungal community in a mouse model of Huntington\u2019s disease. Microbiol Spectr. 2022:10. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35262396\/.","journal-title":"Microbiol Spectr"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103687"},{"key":"e_1_3_4_101_1","first-page":"135","article-title":"Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington\u2019s disease","author":"Kong G","year":"2020","unstructured":"Kong G, Cao KAL, Judd LM, et al. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington\u2019s disease. Neurobiol Dis. 2020:135. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30194046\/","journal-title":"Neurobiol Dis"},{"key":"e_1_3_4_102_1","first-page":"148","article-title":"An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington\u2019s disease","author":"Kong G","year":"2021","unstructured":"Kong G, Ellul S, Narayana VK, et al. An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington\u2019s disease. Neurobiol Dis. 2021:148. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33249136\/","journal-title":"Neurobiol Dis"},{"key":"e_1_3_4_103_1","first-page":"4","article-title":"Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in Huntington\u2019s disease mice","author":"Gubert C","year":"2022","unstructured":"Gubert C, Choo JM, Love CJ, et al. Faecal microbiota transplant ameliorates gut dysbiosis and cognitive deficits in Huntington\u2019s disease mice. Brain Commun. 2022:4. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36035436\/","journal-title":"Brain Commun"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75229-9"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.02.011"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa110"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-220556"},{"key":"e_1_3_4_108_1","first-page":"11","article-title":"Altered gut microbiota related to inflammatory responses in patients with Huntington\u2019s disease","author":"Du G","year":"2021","unstructured":"Du G, Dong W, Yang Q, et al. Altered gut microbiota related to inflammatory responses in patients with Huntington\u2019s disease. Front Immunol. 2021:11. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33679692\/","journal-title":"Front Immunol"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2014.09.011"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu151"},{"key":"e_1_3_4_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43627-3"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116653"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2017.08.013"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84858-7"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4008-12.2012"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00379-3"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1655-22.2022"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096544"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603594"},{"key":"e_1_3_4_120_1","first-page":"3","article-title":"Abnormal peripheral chemokine profile in Huntington\u2019s disease","author":"Wild E","year":"2011","unstructured":"Wild E, Magnusson A, Lahiri Swales N, et al. Abnormal peripheral chemokine profile in Huntington\u2019s disease. PLOS Curr. 2011:3. Available from: \/pmc\/articles\/PMC3082446\/","journal-title":"PLOS Curr"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-130049"},{"key":"e_1_3_4_122_1","first-page":"12","article-title":"Evaluation of blood glial fibrillary acidic protein as a potential marker in Huntington\u2019s disease","author":"You H","year":"2021","unstructured":"You H, Wu T, Du G, et al. Evaluation of blood glial fibrillary acidic protein as a potential marker in Huntington\u2019s disease. Front Neurol. 2021:12. Available from: \/pmc\/articles\/PMC8639701\/","journal-title":"Front Neurol"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2023.100635"},{"key":"e_1_3_4_124_1","first-page":"11","article-title":"Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington\u2019s disease","author":"Rodrigues FB","year":"2016","unstructured":"Rodrigues FB, Byrne LM, McColgan P, et al. Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington\u2019s disease. PLoS One. 2016:11. Available from: \/pmc\/articles\/PMC5033331\/","journal-title":"PLoS One"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1021\/pr0700753"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176363"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.1179\/1743132812Y.0000000073"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00231"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1080\/14789450.2017.1304217"},{"key":"e_1_3_4_130_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-3639.2011.00550.x"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000287"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.08.011"},{"key":"e_1_3_4_133_1","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2009.139"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-2012-120021"},{"key":"e_1_3_4_135_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl013"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M800231-MCP200"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac309"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2022.05.002"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1145649"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.1177\/1091581817740873"},{"issue":"96","key":"e_1_3_4_141_1","article-title":"J08\u2005A phase 2 open label study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous ANX005 in patients with, or at risk of, manifest Huntington\u2019s disease (HD)","volume":"93","author":"Beers B","year":"2022","unstructured":"Beers B, Bredlau A-L, Bhattacharyya A, et al. J08\u2005A phase 2 open label study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous ANX005 in patients with, or at risk of, manifest Huntington\u2019s disease (HD). J Neurol Neurosurg Psychiatry. 2022;93(A96\u2013A97). Available from: https:\/\/jnnp.bmj.com\/content\/93\/Suppl_1\/A96.3.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040527"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2024.2348738","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T04:44:17Z","timestamp":1718685857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2024.2348738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":140,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,3]]}},"alternative-id":["10.1080\/13543784.2024.2348738"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2024.2348738","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}